|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 764 articles |
 Page 1 of 11 
|
Sanofi initiates Ph II trial of melanoma vacc.
September 29, 2008
FDA asks for production info on Actemra BLA.
September 29, 2008
Ovation licenses US rights to Xenazine.
September 29, 2008
Cladribine enters trial in patients at risk of MS.
September 29, 2008
Japan's Astellas buys rights to Maxygen drug in up to $180M agreement.
September 29, 2008
Kemin Pharma opens office in India.
September 29, 2008
India's Lupin buys SA's Pharma Dynamics.
September 29, 2008
Abbott's Humira does well in REVEAL trial.
September 29, 2008
Delay for Cephalon's Fentora sNDA.
September 29, 2008
Teva begins 15B forint expansion of Hungarian facility.
September 29, 2008
BD invests $4.5M in US Genomics.
September 29, 2008
Six-month pediatric extension for AstraZeneca's Casodex.
September 29, 2008
Roche has ample supply of Tamiflu for 2008/9 flu season.
September 29, 2008
Oxea/Chengxing to build Chinese chemical plant.
September 29, 2008
Morphosys joins Novartis antibody program.
September 29, 2008
Teva's ProAir approved for four-year olds.
September 29, 2008
Opexa MS drug fails to meet endpoints.(Clinical report)
September 29, 2008
CLARIFICATION: Wyeth's Viviant Ph III trial.(Correction notice)
September 29, 2008
KaloBios raises $20M financing.
September 29, 2008
SPD Minister attacks Germany's drugmakers.
September 29, 2008
Swiss parallel trade approved by Council of States, with "pharma excep...
September 29, 2008
3.3% pa French health spend target to 2012.
September 29, 2008
"Wide of mark" UK govt free cancer drug plan.
September 29, 2008
Eli Lilly will disclose all payments to US doctors from 2009, despite ...
September 29, 2008
US CMS suspends Part B CAP for Rx drugs.
September 29, 2008
Stock Commentary - Europe - week to Sept 22, 2008.
September 29, 2008
Stock Commentary - New York week to Sept 22, 2008.
September 29, 2008
Nanobiotix/ Malaysian Biotech explain collaboration.
September 29, 2008
Dyax completes BLA for DX-88 in HAE.
September 29, 2008
Novartis starts "squeeze out" for remaining Speedel shares.
September 29, 2008
PolyMedix closes $15M placing.
September 29, 2008
French think-tank attacks [superscript three]sophistry of tax on insur...
September 29, 2008
Merck & Co in-licenses novel osteoanabolic drug from Japan Tabacco.
September 29, 2008
Archimedes debuts Zibor in UK.
September 29, 2008
Takeda files alogliptinand Actos NDA in USA.
September 29, 2008
Ipsen files for EU approval of six-month Decapeptyl.
September 29, 2008
Affitech achieves second Roche milestone.
September 29, 2008
Lilly names John Lechleiter as chairman.
September 29, 2008
Incyte appoints Patricia Andrews as CCO.
September 29, 2008
Belgian Kemin makes Keith Bostian its president.
September 29, 2008
ProFibrix appoints Jan Ohrstrom as COO.
September 29, 2008
Enobia names new VPs: Julie Smith and Javant Aphale.
September 29, 2008
PhRMA announces leadership shake-up.
September 29, 2008
Ligand to acquire Pharmacopeia for $70M.
September 29, 2008
Orphan status for Enobia's ENB-0040.
September 29, 2008
Bristol-Myers Squibb ups offer for ImClone, goes straight to sharehold...
September 29, 2008
Rosetta Genomics transfers project with Isis to Regulus.
September 29, 2008
TRIPS mechanism set to fail as Apotex ships ARV.
September 29, 2008
India hopes for drug boom in FTA with Japan.
September 29, 2008
Thailand's HIV/AIDS drug resistance problem.
September 29, 2008
Good results for Tysabri RMS trial.
September 29, 2008
Acorda reports on MS mobility trial.
September 29, 2008
Merck KGaA Rebif trial meets endpoint.(Clinical report)
September 29, 2008
Biopartners' growth hormone, 3-year data.
September 29, 2008
Bayer data encourages early MS treatment.
September 29, 2008
Baxter initiates Ph III AD trial for Gammagard.
September 29, 2008
Teva presents results from the PreCISe trial.(Clinical report)
September 29, 2008
US drugmakers' groups join forces to warn on medicine abuse dangers.
September 29, 2008
Drugs for acute severe UC to be assessed by UK's NIHR HTA.
September 29, 2008
Early access programs in Europe: a regulatory tool with pre-marketing ...
September 29, 2008
Helix cleared to test topical interferon alpha-2B in Germany.
September 29, 2008
Mylan's generic Parcopa gets FDA OK.
September 29, 2008
Ethnic differences in RA suffers in USA.
September 29, 2008
S*BIO initiates Ph I JAK2 inhibitor trials in USA.
September 29, 2008
Alfacell hires Oppenheimer to study strategic options.
September 29, 2008
ThromboGenics moves up to Belgium's Midcap Index.
September 29, 2008
AMT gains license to Amgen technology for PD candidate.
September 29, 2008
US Rx painkiller overdoses on the rise.
September 29, 2008
EC acts on freedom of pharmacies to set up.
September 29, 2008
US FDA changes cGMP rules on aseptic processing, asbestos and verifica...
September 29, 2008
$11.3M spent by PhRMA on SCHIP ad campaign.
September 29, 2008
Prostrakan a "buy" on early UK Abstral appro.
September 29, 2008
UPDATE: B-MS goes to ImClone shareholders with slightly higher bid, wh...
September 29, 2008
AstraZeneca gets favorable court ruling on Plulmicort; considers brand...
September 29, 2008
Complexity science and systems theory approach to drug markets.
September 29, 2008
|
1